comparemela.com

Latest Breaking News On - Ipca labs - Page 6 : comparemela.com

Unfavourable base drags domestic pharma sales growth to a low 3 5% in November

The domestic pharma s growth of 3.5 percent is the lowest monthly growth this year as a slowdown was seen across all key therapies

F&O stocks: Axis Bank, Page Industries among 5 stocks with short buildup

Coming to the buildup of fresh short positions, when the stock prices move downward and open interest on the counter increases, it is taken as a sign of a long build-up.

InCred sees Nifty FY24 target at 21,103; suggests booking profits in infra stocks

Brokerage house InCred Equities sees FY24 Nifty target at 21,103 and maintains an ‘overweight’ stance. Meanwhile, it recommends booking profits after a 20.8 percent return from the Nifty Infrastructure index in the last six months.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.